Ontology highlight
ABSTRACT: Background
Cognitive behavioral therapy (CBT) is recommended as the first-line treatment for insomnia; however, few patients have access to it. A new class of Food and Drug Administration (FDA)-regulated digital CBT treatments has the potential to address this unmet need. These treatments are ordered or prescribed by health care providers and are fully automated, delivering CBT directly to patients without human coaches. This trial builds upon promising earlier digital cognitive behavioral therapy for insomnia (CBT-I) research by using a decentralized design to recruit a sample with greater representation of the US general population, including individuals from lower socioeconomic status groups who often face greater barriers to care.Objective
This decentralized trial evalu
SUBMITTER: Prather AA
PROVIDER: S-EPMC12715469 | biostudies-literature | 2025 Dec
REPOSITORIES: biostudies-literature